Access Pharmaceuticals, Inc.Dallas, TX, United States (Pink Sheets: ACCP)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Access Pharmaceuticals Financial Statements

Access Pharmaceuticals Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Access Pharmaceuticals Income Statement

  2006 2005 2004
Revenue ($ mil.) 0.0 0.0 0.6
Gross Profit ($ mil.) -- -- 0.3
Operating Income ($ mil.) (5.2) (9.6) (9.1)
Total Net Income ($ mil.) (12.9) (1.7) (10.2)
Diluted EPS (Net Income) (3.65) (0.50) (3.40)
More Access Pharmaceuticals financial information

Access Pharmaceuticals Quarterly Statements

  Quarter Ending Mar 08* Quarter Ending Sep 07 Quarter Ending Jun 07
Revenue ($ mil.) 0.0 0.0 0.0
Gross Profit ($ mil.) -- -- --
Operating Income ($ mil.) (10.6) (1.6) (1.7)
Total Net Income ($ mil.) (10.6) (2.0) (2.1)
Diluted EPS (Net Income) (2.31) (0.55) (0.59)
  • * Irregular reporting interval
More Access Pharmaceuticals financial information

Access Pharmaceuticals Stock Quote & Chart

08/29/08 14:59:49 EST • NASDAQ OTC BB • 3.10 • Increased by +0.2500 • Increased by +8.7719 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Access Pharmaceuticals Financial Ratios

  Company Industry
Median
Market
Median1
Price/Sales Ratio 171.67 3.75 1.56
Price/Earnings Ratio -- 16.34 15.82
Price/Book Ratio -- 2.92 1.52
Price/Cash Flow Ratio -- 13.17 9.88
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Access Pharmaceuticals Financial Ratios

Access Pharmaceuticals Competitive Intelligence

Biovail Bristol-Myers Squibb Endo Pharmaceuticals
Annual Sales ($ mil.) 842.8 19,348.0 1,085.6
Employees 1,533 42,000 1,208
Market Cap ($ mil.) -- 43,191.1 2,794.9

Competitive Landscape